Skip to main content

Table 1 Primary Prevention Research, n = 89

From: Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective

Focus Literature type Countries/Geographic Regions Included
Primary Prevention HPV Vaccination Knowledge/Acceptability/Attitudes
(N = 29)
25 Original research [3941, 126, 127, 130132, 134137, 139, 144151, 158, 180, 256, 257]
2 Review Articles [12, 15]
0 Lessons Learned
2 Policy Papers [167, 258]
Tanzania [126, 180], Uganda [40, 127], Nigeria [131, 137, 256], South Africa [130, 139, 148, 150, 151, 158], Malawi [41], Mali [132, 147], Cameroon [134, 144], Kenya [39, 145, 257], Botswana [135], Ghana [136], Zambia [146], Morocco [149]
Uptake/Retention (N = 10) 6 Original research [43, 153, 155, 157, 159, 160]
1 Review Articles [259]
3 Lessons Learned [154, 156, 260]
0 Policy
Uganda [153, 259, 261], Lesotho [43, 155], Cameroon [43, 155, 156], Tanzania [155, 160], Uganda [155, 157], Kenya [155], South Africa [159], Rwanda [154, 260]
Feasibility (N = 23)
 Cost/cost effectiveness [14, 170, 181, 214, 261269]
 Estimated impact [270272]
 Provider knowledge/training [128, 129, 133, 140143]
21 Original research [128, 129, 133, 140143, 170, 181, 214, 261, 263272]
2 Review Articles [14, 262]
0 Lessons Learned
0 Policy
Tanzania [14, 181, 267, 269], Uganda [14, 267, 271], Sub-Saharan Africa [262, 264], Mali [263, 270], Nigeria [128, 140, 141, 143, 265], South Africa [129, 142, 214], GAVI-eligible countries [266, 268, 272], Kenya [267, 271], Mozambique [271], Zimbabwe [271], Guinea [170], Cameroon [133]
HIV (N = 2) 2 Original research [161, 162]
0 Review Articles
0 Lessons Learned
0 Policy
South Africa [161, 162]
Males (N = 1) 1 Original research [138]
0 Review Articles
0 Lessons Learned
0 Policy
Uganda [138]
Other (N = 11)
 Safety/Immunogenicity (n = 2) [164, 165]
 Adverse Events (n = 1) [166], Barriers (n = 1) [42], Policy (n = 6) [168, 169, 273276], Conference Summary (n = 1) [152]
3 Original research [164166]
2 Review Articles [42, 152]
0 Lessons Learned
6 Policy [168, 169, 273276]
Uganda [166, 168, 274], Senegal [164], Tanzania [164, 165], Low-Middle Income Countries [42, 273, 276], Middle East/North Africa [275], Sub-Saharan Africa [152, 169]
Primary Prevention (HPV Vaccine)
Total = 76
59 Original research
6 Review Articles
3 Lessons Learned
8 Policy
South Africa 12, Uganda 12, Tanzania 10, Nigeria 8, Cameroon 6, Kenya 6, Mali 4, Low-Middle Income Countries 3, GAVI Eligible Countries 3, Lesotho 2, Rwanda 2, sub-Saharan Africa 4, Malawi 1, Botswana 1, Ghana 1, Zambia 1, Morocco 1, Ivory Coast 1, Mozambique 1, Zimbabwe 1, Middle East/North Africa 1, Guinea 1
Non-Vaccine Prevention Male Circumcision (N = 10) 10 Original research [4648, 171176, 277]
0 Review Articles
0 Lessons Learned
0 Policy
Uganda [47, 48, 171174, 176, 277], South Africa [46, 175]
Condoms (N = 1) 1 Original research [179]
0 Review Articles
0 Lessons Learned
0 Policy
South Africa [179]
Lubricant Gel, Microbicides and/or Diaphragm (N = 2) 2 Original research [177, 178]
0 Review Articles
0 Lessons Learned
0 Policy
South Africa [178], Zimbabwe [177]
Primary Prevention (Non-Vaccine)
Total = 13
13 Original research Uganda (8), South Africa (4), Zimbabwe (1)